Windlas Biotech Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Efficient capital deployment (ROCE 15.9%)
- Attractively valued vs sector (P/E 35x vs industry 54.7x)
- Virtually debt-free
Concerns
- Trading near 52-week high (₹1,152)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
WINDLAS · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 62.82% | 62.82% | 62.51% | 62.51% | 62.51% | 62.34% |
| FII | 1.35% | 1.18% | 1.59% | 2.00% | 1.55% | 1.52% |
| DII | 11.71% | 11.82% | 10.35% | 9.58% | 10.26% | 10.89% |
| Public | 24.11% | 24.19% | 25.55% | 25.91% | 25.67% | 25.25% |
Latest News
All newsWindlas Biotech hosts Q1 FY27 analyst call
*Windlas Biotech hosts Q1 FY27 analyst call*. Company shared updates during its investor meet for the first quarter of FY27. No major financial announcements or guidance changes were disclosed. The call primarily focused on operational performance and market outlook. 📊 *STOCKS:* $WINDLASBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Earnings
Windlas Biotech hosts analyst call for investors
*Windlas Biotech hosts analyst call for investors.* The company provided updates during its recent analyst and institutional investor meet. A recording of the session is available for review. No major financial announcements or guidance changes were disclosed. 📊 *STOCKS:* $WINDLASBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AnalystCall
Windlas Biotech to host analyst meet for investors
*Windlas Biotech to host an analyst and institutional investor meet.* The event aims to provide updates on company performance and strategy. **No financial figures or major announcements** were disclosed in the filing. It’s a routine engagement for investor communication. 📊 *STOCKS:* $WINDLAS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AnalystMeet
Windlas Biotech to host analyst and investor meet
*Windlas Biotech to host analyst and investor meet.* The company has announced a schedule for its upcoming analyst and institutional investor meet. Details on business performance and strategy may be discussed. No financial figures or major announcements were disclosed in the filing. 📊 *STOCKS:* $WINDLAS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Invest0rMeet
Windlas Biotech to hold shareholder meeting on July 23, 2026
*Windlas Biotech to hold shareholder meeting on July 23, 2026.* The meeting is scheduled for discussions on routine corporate matters. No **major financial figures** or strategic announcements disclosed yet. Such events typically precede disclosures on capital structure or governance. 📊 *STOCKS:* WINDLASBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholderMeeting
Windlas Biotech sets dividend record date
*Windlas Biotech sets dividend record date.* The company has announced **16-Jul-2026** as the record date for dividend distribution. Shareholders registered on this date will be eligible for the payout. Details of dividend amount and payment date will be disclosed separately. 📊 *STOCKS:* WINDLAS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #dividend
Windlas Biotech publishes mandatory newspaper notice
*Windlas Biotech publishes mandatory newspaper notice.* This is a routine regulatory disclosure as per corporate filing norms. **No financial or operational update** was provided in the notice. It does not indicate any immediate business development or change. 📊 *STOCKS:* WBL | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CorporateFiling
Windlas Biotech to host analyst and investor meet
*Windlas Biotech to host analyst and investor meet.* The company has scheduled a conference call for institutional investors and analysts. Details are available in a recent NSE corporate filing. Purpose appears to be updates on business performance and strategy. 📊 *STOCKS:* WINDLASBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Earnings
Windlas Biotech to host analyst investor meet
*Windlas Biotech to host analyst and institutional investor meet.* The event aims to provide updates on company performance and strategy. **No financial figures or major announcements** were disclosed in the filing. Details on timing and agenda will follow. 📊 *STOCKS:* WINDLASBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Earnings